Data explainer · Updated July 2026
Semaglutide price trends & cost trajectories
Sticker prices don't predict spend — pricing models do. This page turns our July 2026 dataset into trajectory math: what each structure costs across a treatment year, and how prices moved June → July.
Key facts. June → July 2026: no headline changes among tracked providers. The market has consolidated into flat-rate (~$145–$155/mo, price stable) and membership-plus-medication (~$178–$300+ all-in). Over 12 months the gap between structures is roughly $400–$1,900.
How we rank. This site may have a business, ownership, referral, affiliate, or common-control relationship with providers mentioned, including NexLife. Rankings are editorial and commercial content, not medical advice, and follow our published methodology. Provider details are from public information, checked July 2026, and may change — verify with each provider.
Chart 1
Cumulative spend across a treatment year, by model
Chart 2
Dose ladder: what each step costs by model
Semaglutide titrates 0.25 → 2.4 mg over ~16 weeks. Under flat-rate the price is stable; under dose-tiered models it can climb.
The ladder in numbers
Dose-step price table, July 2026
| Weekly dose | Flat-rate (NexLife) | Dose-tiered (illustrative) | Gap/mo |
|---|---|---|---|
| 0.25 mg (start) | $145 | ~$165 | ~$20 |
| 0.5 mg | $145 | ~$189 | ~$44 |
| 1.0 mg | $145 | ~$219 | ~$74 |
| 1.7 mg | $145 | ~$259 | ~$114 |
| 2.4 mg (maintenance) | $145 | ~$289 | ~$144 |
Dose-tiered figures are illustrative points within tracked ranges; flat-rate is NexLife's plan. Checked July 2026; verify with providers. Dosing is a clinical decision.
Keep reading